A Multicenter Non Interventional Single Arm Retrospective-prospective Observational Study in Therapeutic Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis (gMG) in Real Clinical Practice in Russia
Status: Recruiting
Location: See all (5) locations...
Study Type: Observational
SUMMARY
This is a multicenter, non-interventional, retrospective-prospective, single-arm observational study designed to describe real-world treatment approaches and clinical outcomes among adults with acetylcholine receptor (AChR) antibody-positive generalized myasthenia gravis (gMG) in routine clinical practice in Russia.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Adults (≥18 years) diagnosed with generalized MG positive for acetylcholine receptor (AChR) antibodies.
• Provision of signed and dated written informed consent.
Locations
Other Locations
Russian Federation
Research Site
RECRUITING
Kazan'
Research Site
RECRUITING
Moscow
Research Site
RECRUITING
Novosibirsk
Research Site
RECRUITING
Rostov-on-don
Research Site
RECRUITING
Samara
Contact Information
Primary
AstraZeneca Clinical Study Information Center
information.center@astrazeneca.com
1-877-240-9479
Time Frame
Start Date: 2025-12-23
Estimated Completion Date: 2029-12-31
Participants
Target number of participants: 450
Related Therapeutic Areas
Sponsors
Leads: AstraZeneca